two
potenti
receptor
describ
felin
infecti
periton
viru
fipv
felin
aminopeptidas
n
fapn
felin
dendrit
cellspecif
intercellular
adhes
molecul
grab
nonintegrin
fdcsign
cell
line
fapn
serv
receptor
serotyp
ii
serotyp
fipv
role
fapn
infect
vivo
target
cell
monocyt
yet
confirm
serotyp
ii
fipv
use
fdcsign
infect
monocytederiv
cell
known
studi
role
fapn
fdcsign
studi
differ
stage
fipv
infect
monocyt
first
effect
block
potenti
receptor
studi
process
attach
infect
secondli
level
coloc
fipv
receptor
determin
found
fipv
bind
infect
affect
block
fapn
block
fdcsign
reduc
fipv
bind
practic
complet
inhibit
infect
accordingli
bound
fipv
particl
coloc
fdcsign
block
fapn
reduc
fipv
ii
bind
infect
bound
fipv
ii
coloc
fapn
fdcsign
involv
fipv
ii
bind
infect
reduc
fdcsign
block
conclus
fipv
infect
monocyt
depend
fdcsign
fipv
particl
alreadi
interact
fdcsign
plasma
membran
fipv
ii
fapn
fdcsign
involv
infect
fapn
play
receptor
role
plasma
membran
felin
coronavirus
fcov
belong
coronaviru
subgroup
two
pathotyp
describ
often
clinic
unappar
enter
felin
coronaviru
fecv
deadli
felin
infecti
periton
viru
fipv
pathotyp
belong
either
serotyp
ii
serotyp
caus
natur
infect
wherea
serotyp
ii
infect
rare
serotyp
ii
mostli
use
research
purpos
grow
better
cultur
pedersen
et
al
process
viral
entri
attract
target
develop
new
therapeut
agent
therefor
lot
research
focuss
entri
process
rang
virus
cooley
lewin
timp
mckeat
led
develop
number
promis
agent
exampl
treatment
cooley
lewin
last
coupl
year
knowledg
entri
felin
coronavirus
host
cell
expand
bind
receptor
fipv
intern
monocyt
endocytosi
specif
via
clathrinand
caveolaeindepend
pathway
use
dynamin
van
hamm
et
al
accord
subsequ
escap
endosom
mediat
cathepsin
b
fipv
strain
enter
strain
low
ph
endocyt
compart
cathepsin
l
need
assist
cathepsin
b
contrast
de
haan
et
al
observ
infect
fipv
appear
insensit
cathepsin
inhibitor
two
potenti
receptor
describ
felin
coronavirus
first
one
aminopeptidas
n
apn
also
design
ubiquit
multifunct
glycoprotein
approxim
kda
amino
acid
luan
xu
type
ii
metalloproteas
contain
seven
domain
et
al
domain
vvii
interact
form
noncoval
link
homodim
et
al
felin
apn
fapn
serv
receptor
felin
canin
porcin
human
coronavirus
coronaviru
subgroup
tresnan
et
al
howev
serotyp
ii
serotyp
fcov
strain
abl
recogn
fapn
hohdatsu
et
al
dye
et
al
teke
et
al
bind
serotyp
ii
strain
fapn
cell
line
block
complet
monoclon
antibodi
bind
region
fapn
aa
aa
ie
domain
v
vi
hohdatsu
et
al
tusel
et
al
interact
fipv
fapn
mainli
studi
cell
line
mean
fapn
cdna
clone
origin
cell
line
secondli
describ
serotyp
ii
fcov
use
dendrit
cell
dc
specif
intercellular
adhes
molecul
icam
grab
nonintegrin
dcsign
entri
crandel
felin
kidney
crfk
cell
mous
cell
transfect
dcsign
monocyt
dcsign
ctype
lectin
impli
recogn
ligand
highmannos
oligosaccharid
ca
depend
carbohydraterecognit
domain
drickam
mani
virus
hiv
ebola
hepat
c
use
dcsign
homologu
lsign
express
liver
lymph
node
augment
infect
geijtenbeek
et
al
alvarez
et
al
lozach
et
al
et
al
coronavirus
also
interact
lectin
sarscov
dcsign
lsign
enhanc
infect
cell
coexpress
major
sar
receptor
jeffer
et
al
marzi
et
al
yang
et
al
dcsign
lsign
similarli
augment
infect
human
coronaviru
hcov
also
reli
infecti
entri
hofmann
et
al
lsign
express
nonsuscept
cell
bind
jeffer
et
al
serotyp
ii
fcov
express
human
dcsign
crfk
cell
induc
increas
infect
block
mannan
competitor
dcsign
bind
infect
felin
monocyt
vivo
target
cell
strongli
reduc
mannan
recent
data
extend
shown
type
type
ii
fcov
use
felin
dcsign
infect
monocytederiv
dendrit
cell
regan
et
al
clearli
previou
research
focuss
interact
fcov
cell
line
known
data
extrapol
vivo
target
cell
monocyt
knowledg
requir
want
target
entri
process
antivir
therefor
role
candid
receptor
determin
multistep
entri
process
blood
monocyt
effect
block
fapn
fdcsign
studi
process
attach
infect
fipv
strain
black
serotyp
serotyp
ii
addit
coloc
studi
perform
fipv
potenti
receptor
aim
studi
understand
fipv
interact
receptor
primari
fipv
target
cell
vivo
blood
monocyt
felin
blood
monocyt
isol
blood
collect
felin
coronaviru
felin
leukaemia
viru
felin
immunodefici
virusneg
cat
cultur
describ
dewerchin
et
al
kinet
attach
intern
monocyt
cat
describ
van
hamm
et
al
cat
refer
cat
crfk
cell
purchas
atcc
cho
control
cell
cho
transfect
stabli
express
wildtyp
human
dcsign
de
witt
et
al
gift
geijtenbeek
depart
molecular
cell
biolog
immunolog
vu
univers
medic
centr
amsterdam
amsterdam
netherland
fipv
serotyp
strain
black
fipv
passag
fcwf
cell
serotyp
ii
strain
wsu
fipv
ii
crfk
cell
black
kind
gift
dr
egberink
depart
infecti
diseas
immunolog
utrecht
univers
utrecht
netherland
monoclon
antibodi
mab
direct
felin
aminopeptidas
n
fapn
hohdatsu
et
al
kind
gift
dr
hohdatsu
depart
veterinari
infecti
diseas
towada
japan
monoclon
antibodi
fapn
purchas
veterinari
medic
research
develop
vmrd
pullman
usa
polyclon
mous
antibodi
rais
fulllength
human
dcsign
also
design
purchas
abnova
taipei
taiwan
mab
vmrd
use
stain
plasma
membran
monocyt
antibodi
use
stain
random
membran
protein
surfac
monocyt
immunoglobulin
pseudorabi
viru
gd
produc
laboratori
nauwynck
pensaert
use
irrelev
isotypematch
control
antibodi
polyclon
antifipv
antibodi
fipv
serotyp
strain
isol
ascit
cat
fip
polyclon
antifipv
antibodi
fipv
serotyp
ii
strain
wsu
kind
gift
dr
rottier
depart
infecti
diseas
immunolog
utrecht
netherland
fitclabel
polyclon
antibodi
fipv
purchas
vmrd
experiment
design
studi
attach
separ
time
point
use
evalu
potenc
inhibit
process
determin
base
data
obtain
earlier
kinet
attach
intern
fipv
van
hamm
et
al
monocyt
crfk
cell
experi
fipv
ii
wash
h
postseed
chill
c
min
preincub
c
min
mab
mgml
andor
mannan
mgml
irrelev
isotypematch
mab
pretreat
fipv
ad
cell
multipl
infect
moi
fipv
moi
fipv
ii
result
concentr
mgml
antibodi
andor
mgml
mannan
cell
viru
incub
c
h
monocyt
h
crfk
cho
cell
cell
wash
icecold
rpmi
fix
paraformaldehyd
bound
particl
stain
antifipvbiotin
follow
streptavidinfitc
molecular
probesinvitrogen
merelbek
belgium
mount
coverslip
attach
quantifi
per
cell
count
number
bound
particl
least
cell
h
postseed
cell
wash
rpmi
preincub
h
c
mab
andor
mannan
irrelev
isotypematch
mab
pretreat
fipv
ad
cell
moi
fipv
moi
fipv
ii
h
inoculum
replac
medium
supplement
antibodi
mannan
concentr
pretreat
cell
incub
anoth
h
c
final
cell
wash
fix
permeabil
triton
min
room
temperatur
permeabil
follow
h
incub
c
antifipvfitc
min
hoechst
molecular
probe
coverslip
mount
onto
microscop
slide
analyz
fluoresc
microscopi
cell
cytoplasm
express
viral
protein
score
infect
cell
cell
coverslip
evalu
h
postseed
cell
wash
rpmi
preincub
h
c
mannan
pretreat
fitclabel
albumin
transferrin
ad
cell
h
cell
wash
icecold
rpmi
fix
paraformaldehyd
phosphat
buffer
salin
ph
cortic
actin
stain
phalloidintexa
red
molecular
probesinvitrogen
mount
coverslip
intern
quantifi
per
cell
monocyt
crfk
cell
cho
cell
wash
h
postseed
chill
c
min
cell
inocul
fipv
moi
fipv
moi
fipv
ii
cell
viru
incub
c
h
cell
wash
icecold
rpmi
fix
paraformaldehyd
bound
particl
stain
antifipvbiotin
follow
streptavidinfitc
molecular
probesinvitrogen
slide
incub
mab
stain
fapn
mous
pab
antidcsign
antibodi
stain
dcsign
mab
use
visual
vmrd
conjug
texa
redlabel
goat
antimous
antibodi
use
molecular
probe
coverslip
mount
onto
microscop
slide
analyz
confoc
microscopi
infect
assay
analyz
dm
irb
invert
microscop
leica
microsystem
gmbh
wetzlar
germani
attach
coloc
assay
analyz
leica
tc
laser
scan
spectral
confoc
system
link
dm
irb
invert
microscop
leica
argon
hene
laser
use
excit
fitc
texa
red
fluorochrom
respect
leica
confoc
softwar
use
imag
acquisit
triplic
assay
perform
compar
mannwhitney
u
test
use
spss
softwar
packag
version
spss
inc
chicago
il
usa
p
valu
consid
significantli
differ
fapn
present
monocyt
express
plasma
membran
well
cytosol
assess
stain
mab
permeabil
fig
howev
remark
epitop
appear
abundantli
present
extracellularli
approxim
monocyt
permeabil
epitop
could
detect
cell
fig
contrast
crfk
cell
epitop
extracellularli
present
cell
data
shown
suggest
express
pattern
andor
conform
apn
cell
type
depend
furthermor
shown
extracellular
express
epitop
monocyt
increas
time
cell
extracellular
epitop
express
day
cell
extracellular
express
day
post
seed
data
shown
dcsign
practic
monocyt
express
substanti
amount
dcsign
plasma
membran
well
intracellularli
fig
role
fapn
entri
mediat
evalu
inhibit
studi
mab
coloc
studi
fipv
fapn
assess
involv
fdcsign
inhibit
studi
mannan
perform
coloc
fipv
antigen
felin
dcsign
studi
monocyt
fipv
bind
affect
mab
fig
bound
fipv
coloc
significantli
fapn
irrelev
protein
fig
suggest
viru
interact
fapn
bind
receptor
expect
shown
fig
presenc
mab
inhibit
fipv
infect
monocyt
taken
togeth
data
show
aminopeptidas
n
involv
entri
process
fipv
monocyt
pre
incub
monocyt
mannan
block
fdcsign
reduc
viru
bind
significantli
bind
observ
control
cell
fig
fapn
fdcsign
block
respect
mannan
viru
bind
reduc
bind
observ
control
cell
fig
clear
epitop
apn
recogn
involv
interact
fipv
dcsign
contrari
reduct
viru
bind
slightli
smaller
compar
reduct
caus
mannan
alon
possibl
presenc
mab
impair
bind
mannan
coloc
bound
fip
virion
fdcsign
confirm
role
viru
bind
fig
infect
reduc
mannantr
cell
infect
control
cell
impli
bind
fipv
dcsign
result
infect
reduct
infect
higher
reduct
viru
bind
therefor
possibl
dcsign
also
involv
process
downstream
viru
bind
approach
use
describ
fipv
use
approach
could
confirm
fapn
major
receptor
fipv
ii
infecti
entri
crfk
cell
treatment
mab
complet
block
bind
fipv
ii
bound
particl
coloc
complet
fapn
like
fapn
also
involv
subsequ
intern
viru
crfk
cell
fipv
found
coloc
fapn
insid
cell
data
shown
mab
also
block
infect
fig
therefor
intern
bind
fapn
lead
infect
fapn
necessari
receptor
fipv
ii
infect
crfk
cell
line
incub
cell
mab
attach
fipv
ii
significantli
reduc
attach
control
cell
fig
inhibit
complet
like
observ
crfk
cell
infect
also
significantli
reduc
control
treat
cell
mab
impli
particl
intern
bind
fapn
product
infect
monocyt
coloc
studi
show
fipv
ii
particl
bound
monocyt
coloc
fapn
fig
amount
coloc
significantli
higher
expect
base
coincid
shown
coloc
stain
fipv
ii
irrelev
surfac
protein
confirm
involv
fapn
viru
bind
monocyt
howev
fraction
bind
infect
fipv
ii
still
unaccount
indic
fapn
role
fdcsign
bind
intern
fipv
ii
monocyt
evalu
fig
show
block
fdcsign
mannan
signific
effect
viru
bind
confirm
fact
combin
mannan
significantli
increas
inhibit
attach
caus
result
coloc
studi
fipv
ii
fdcsign
monocyt
support
conclus
observ
coloc
significantli
exceed
level
background
coloc
fig
infect
unlik
attach
reduct
infect
untreat
cell
observ
mannan
ad
suggest
fdcsign
involv
infect
primari
cell
mab
mannan
ad
cell
infect
reduc
significantli
infect
control
cell
compar
apn
block
base
result
appear
fdcsign
seem
play
role
infect
process
albeit
initi
bind
underli
mechan
remain
elus
thu
far
besid
role
fcov
infect
monocyt
dcsign
interact
numer
virus
like
hiv
ebola
hepat
c
mani
other
geijtenbeek
et
al
alvarez
et
al
lozach
et
al
et
al
therefor
one
might
question
specif
interact
make
sure
effect
mannan
specif
evalu
influenc
mannan
intern
cellular
compon
albumin
transferrin
mannan
affect
intern
process
thu
effect
mannan
entri
infect
determin
previou
assay
virusdepend
data
shown
studi
show
fipv
infect
monocyt
depend
fdcsign
fipv
particl
alreadi
interact
fdcsign
plasma
membran
fipv
ii
fapn
fdcsign
involv
infect
fapn
play
receptor
role
plasma
membran
studi
fipv
entri
process
vivo
target
cell
monocyt
provid
import
inform
obtain
studi
cell
line
experiment
data
indic
fdcsign
import
viru
bind
receptor
fipv
fapn
howev
probabl
anoth
receptor
besid
fdcsign
involv
exclud
fapn
interact
ineffici
fipv
epitop
differ
epitop
suggest
teke
et
al
interact
would
inhibit
coloc
assay
reveal
high
level
coloc
background
due
coincid
contrast
fdcsign
receptor
fipv
ii
fapn
respons
major
fipv
ii
bind
howev
fapn
viru
bind
receptor
fipv
ii
monocyt
like
crfk
cell
block
fapn
complet
prevent
infect
remain
possibl
intern
receptor
also
lead
infect
independ
apn
although
involv
viru
bind
dcsign
import
fipv
ii
infect
like
step
intern
sarscov
infect
also
reduc
without
affect
viru
bind
compound
target
highmannos
oligosaccharid
okeef
et
al
suggest
highmannos
oligosaccharid
import
entri
possibl
fusion
result
suggest
similar
role
highmannos
fipv
entri
process
interact
dcsign
paper
show
dcsign
play
differ
pronounc
role
fipv
infect
fipv
ii
infect
also
illustr
suscept
cho
cell
stabli
express
hdcsign
infect
enger
et
al
fipv
replic
well
cell
fipv
ii
abl
infect
cell
vitro
none
serotyp
infect
untransduc
cho
cell
data
shown
list
result
studi
comparison
made
result
obtain
regan
et
al
studi
limit
data
describ
happen
target
cell
conclus
entri
factor
sole
base
infect
assay
fipv
regan
et
al
report
almost
complet
reduct
infect
felin
monocytederiv
dendrit
cell
dc
accord
find
monocyt
type
ii
strong
incomplet
reduct
infect
report
monocyt
monocytederiv
dendrit
cell
reduct
infect
monocyt
compar
find
appar
mannan
stronger
effect
type
infect
type
ii
infect
monocyt
monocytederiv
dc
experi
fipv
perform
lower
moi
fipv
ii
moi
vs
amount
viru
ad
cell
might
influenc
receptor
util
sever
virus
describ
effect
block
dcsign
higher
low
moi
low
receptor
avail
de
parsev
et
al
accordingli
effect
block
dcsign
pronounc
fipv
strain
use
lower
moi
concern
vivo
relev
result
seem
like
fipv
preval
field
dcsign
play
role
captur
viru
particl
first
stage
infect
low
number
viru
particl
present
compar
low
moi
vitro
possibl
peripheri
pyogranuloma
later
stage
infect
high
number
viru
particl
present
compar
high
moi
vitro
fdcsign
might
less
import
level
viru
bind
data
obtain
studi
lead
hypothet
model
fipv
entri
monocyt
depict
fig
type
viru
bind
fdcsign
result
infect
viru
also
bind
anoth
unknown
receptor
receptor
x
fig
follow
bind
unidentifi
receptor
viru
particl
might
unabl
induc
infect
infect
might
mediat
cascad
event
fdcsign
play
role
type
ii
viru
bind
fapn
intern
cell
via
receptor
particl
intern
via
pathway
lead
infect
cell
second
unknown
receptor
also
bind
fipv
ii
receptor
fig
pathway
might
also
lead
infect
fdcsign
unknown
receptor
fulfil
role
infect
step
viru
bind
hypothet
fdcsign
might
involv
genom
releas
viru
enter
cell
via
fapn
andor
unknown
receptor
possibl
propos
pathway
type
ii
use
unknown
receptor
dcsign
might
also
use
type
fipv
receptor
x
receptor
upon
recombin
event
canin
cov
fipv
ii
might
lost
abil
effici
infect
unknown
receptor
dcsign
like
fipv
gain
effici
interact
apn
taken
togeth
studi
role
aminopeptidas
n
dcsign
receptor
fipv
analyz
first
time
vivo
target
cell
monocyt
protein
shown
import
fipv
infect
check
whether
necessari
viru
bind
plasma
membran
downstream
intern
pathway
specif
inform
avail
till
although
crucial
develop
antivir
drug
base
data
obtain
cell
line
besid
elucid
aspect
fipv
entri
monocyt
new
insight
reveal
much
unknown
fipv
entri
studi
remind
result
studi
obtain
cell
cultur
analyz
care
know
virus
use
differ
receptor
varieti
cellular
protein
gain
entri
differ
cell
